The Gamaleya Center successfully developed and registered in 2015 two vector-based vaccines against Ebola fever (another vaccine was registered in 2020). The vaccines have been officially approved for use by the Russian Health Ministry. Аbout 2,000 people in Guinea received injections of Gamaleya vaccines in 2017-18. Gamaleya Research Center received an international patent for Ebola vaccine.
References and links for registration certificates, international patents and scientific publications about vaccines developed by the Gamaleya center
1. Gamaleya EBOLA vaccine
Russian Health Ministry registration certificates:
Dolzhikova IV, Zubkova OV, Tukhvatulin AI, et al. Safety and immunogenicity of GamEvac-Combi, a heterologous VSV- and Ad5-vectored Ebola vaccine: An open phase I/II trial in healthy adults in Russia. Hum Vaccin Immunother. 2017